Carmen Masson, PhD

Title(s)Professor, Psychiatry
SchoolSchool of Medicine
Address2540 23rd Street, #5804
San Francisco CA 94110
Phone415-476-0125
vCardDownload vCard
    Other Positions
    Title(s)UCSF Weill Institute for Neurosciences


    Collapse Overview 

    Collapse Research 
    Collapse research activities and funding
    Expanding Access to Buprenorphine Treatment among Homeless Persons with Opioid Use Disorder
    NIH R21DA050038Aug 1, 2020 - Jul 31, 2022
    Role: Principal Investigator
    Digital Health Technology Use Among Methadone Maintenance Patients
    NIH R21DA038304Jul 1, 2015 - Dec 31, 2018
    Role: Principal Investigator
    Mentoring Emerging Scientists for Careers in Substance Use Research
    NIH R25DA035163May 1, 2014 - Apr 30, 2024
    Role: Principal Investigator
    Hepatitis Care Coordination in Methadone Treatment
    NIH R01DA020781Sep 30, 2006 - Apr 30, 2013
    Role: Principal Investigator
    PREVENTION OF INFECTIOUS DISEASE IN INJECTION DRUG USERS
    NIH K01DA000408Mar 20, 1999 - Sep 30, 2004
    Role: Principal Investigator
    REFERRAL SERVICE FOR SUBSTANCE ABUSERS AT RISK FOR AIDS
    NIH F32DA005768Mar 27, 1997
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Barriers to Buprenorphine Treatment Among People Experiencing Homelessness: A Qualitative Study from the Provider Perspective. J Urban Health. 2025 Apr; 102(2):465-475. Masson CL, Knight KR, Levine EA, Spillane JA, Liang YCA, Suen LW, Chen MM, Zevin B, Schwartz RP, Coffin PO, Sorensen JL. PMID: 40148731; PMCID: PMC12031702.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Predictors of Buprenorphine Formulation Preferences Among Individuals Experiencing Homelessness With Opioid Use Disorder. Drug and Alcohol Dependence. 2025 Feb 1; 267:112243. Masson MC, Shopshire SM, Knight KK, Suen SL, Swinkels SM, Schwartz SR, Coffin CP, Sorensen SJ. .
      View in: Publisher Site   Mentions:
    3. Substance use Attitudes, Beliefs, Experience, and Knowledge Among Nursing and Nursing Assistant Students. J Psychoactive Drugs. 2024 Apr 22; 1-11. Fokuo JK, Hutman PJ, Gruber VA, Masson CL, Lum PJ, Bush DM, Naugle JA, Sorensen JL. PMID: 38646910; PMCID: PMC11493843.
      View in: PubMed   Mentions:    Fields:    
    4. A cluster-randomized trial of a brief multi-component intervention to improve tobacco outcomes in substance use treatment. Subst Abuse Treat Prev Policy. 2023 06 16; 18(1):34. Guydish J, McCuistian C, Hosakote S, Le T, Masson CL, Campbell BK, Delucchi K. PMID: 37328775; PMCID: PMC10276468.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Lifetime use of non-nicotine drugs in electronic cigarette devices among a sample of individuals in substance use disorder treatment. Addict Behav Rep. 2022 Dec; 16:100465. Masson CL, Gubner NR, Benowitz N, Hosakote S, Le T, Guydish JR. PMID: 36341309; PMCID: PMC9633988.
      View in: PubMed   Mentions: 3  
    6. Pre-implementation Assessment of Tobacco Cessation Interventions in Substance Use Disorder Residential Programs in California. Subst Use Misuse. 2022; 57(9):1345-1355. Fokuo JK, McCuistian CL, Masson CL, Gruber VA, Straus E, Wong J, Guydish JR. PMID: 35621319; PMCID: PMC10083040.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    7. Formal Hepatitis C Education Increases Willingness to Receive Therapy in an On-site Shelter-Based HCV Model of Care in Persons Experiencing Homelessness. Open Forum Infect Dis. 2022 Apr; 9(4):ofac103. Partida D, Powell J, Ricco M, Naugle J, Magee C, Zevin B, Masson CL, Konadu Fokuo J, Gonzalez D, Khalili M. PMID: 35369281; PMCID: PMC8968162.
      View in: PubMed   Mentions: 6  
    8. Erratum to: Adherence to Hepatitis C Therapy in a Shelter-Based Education and Treatment Model Among Persons Experiencing Homelessness. Open Forum Infect Dis. 2022 Mar; 9(3):ofab652. Powell J, Ricco M, Naugle J, Magee C, Hassan H, Masson C, Braimoh G, Zevin B, Khalili M. PMID: 35224129; PMCID: PMC8865382.
      View in: PubMed   Mentions:
    9. Cost of Hepatitis C care facilitation for HIV/Hepatitis C Co-infected people who use drugs. Drug Alcohol Depend. 2022 03 01; 232:109265. Gutkind S, Starbird LE, Murphy SM, Teixeira PA, Gooden LK, Matheson T, Feaster DJ, Jain MK, Masson CL, Perlman DC, Del Rio C, Metsch LR, Schackman BR. PMID: 35042101; PMCID: PMC9238179.
      View in: PubMed   Mentions: 2     Fields:    
    10. Shelter-Based Integrated Model Is Effective in Scaling Up Hepatitis C Testing and Treatment in Persons Experiencing Homelessness. Hepatol Commun. 2022 01; 6(1):50-64. Khalili M, Powell J, Park HH, Bush D, Naugle J, Ricco M, Magee C, Braimoh G, Zevin B, Fokuo JK, Masson CL. PMID: 34628726; PMCID: PMC8710795.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    11. Adherence to Hepatitis C Therapy in a Shelter-Based Education and Treatment Model Among Persons Experiencing Homelessness. Open Forum Infect Dis. 2021 Oct; 8(10):ofab488. Powell J, Ricco M, Naugle J, Magee C, Hassan H, Masson C, Braimoh G, Zevin B, Khalili M. PMID: 34651053; PMCID: PMC8507447.
      View in: PubMed   Mentions: 1  
    12. Care Facilitation Advances Movement Along the Hepatitis C Care Continuum for Persons With Human Immunodeficiency Virus, Hepatitis C, and Substance Use: A Randomized Clinical Trial (CTN-0064). Open Forum Infect Dis. 2021 Aug; 8(8):ofab334. Metsch LR, Feaster DJ, Gooden LK, Masson C, Perlman DC, Jain MK, Matheson T, Nelson CM, Jacobs P, Tross S, Haynes L, Lucas GM, Colasanti JA, Rodriguez A, Drainoni ML, Osorio G, Nijhawan AE, Jacobson JM, Sullivan M, Metzger D, Vergara-Rodriguez P, Lubelchek R, Duan R, Batycki JN, Matthews AG, Munoz F, Jelstrom E, Mandler R, Del Rio C. PMID: 34377726; PMCID: PMC8339611.
      View in: PubMed   Mentions: 6  
    13. COVID-19 vaccine trust among clients in a sample of California residential substance use treatment programs. Drug Alcohol Depend. 2021 08 01; 225:108812. Masson CL, McCuistian C, Straus E, Elahi S, Chen M, Gruber VA, Le T, Guydish J. PMID: 34174773; PMCID: PMC8221747.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    14. Patient-reported experiences with direct acting antiviral therapy in an integrated model of hepatitis C care in homeless shelters. J Viral Hepat. 2021 10; 28(10):1488-1490. Kim S, Powell J, Naugle J, Ricco M, Magee C, Masson C, Zevin B, Bush D, Khalili M. PMID: 34003525; PMCID: PMC8574070.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    15. Correlates of e-cigarette use for smoking cessation among clients in residential substance use disorder treatment. Addict Behav. 2021 08; 119:106947. Masson CL, Le T, Hosakote S, Fokuo JK, Gubner NR, Shingle M, Guydish J. PMID: 33892312; PMCID: PMC8247797.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    16. Clients' perceptions of barriers and facilitators to implementing hepatitis C virus care in homeless shelters. BMC Infect Dis. 2020 May 29; 20(1):386. Masson CL, Fokuo JK, Anderson A, Powell J, Zevin B, Bush D, Khalili M. PMID: 32471376; PMCID: PMC7260732.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    17. Recommendations for Implementing Hepatitis C Virus Care in Homeless Shelters: The Stakeholder Perspective. Hepatol Commun. 2020 May; 4(5):646-656. Fokuo JK, Masson CL, Anderson A, Powell J, Bush D, Ricco M, Zevin B, Ayala C, Khalili M. PMID: 32363316; PMCID: PMC7193125.
      View in: PubMed   Mentions: 19     Fields:    
    18. Health-related internet use among opioid treatment patients. Addict Behav Rep. 2019 Jun; 9:100157. Masson CL, Chen IQ, Levine JA, Shopshire MS, Sorensen JL. PMID: 31193741; PMCID: PMC6542730.
      View in: PubMed   Mentions: 11  
    19. Cost-effectiveness of hepatitis C screening and treatment linkage intervention in US methadone maintenance treatment programs. Drug Alcohol Depend. 2018 04 01; 185:411-420. Schackman BR, Gutkind S, Morgan JR, Leff JA, Behrends CN, Delucchi KL, McKnight C, Perlman DC, Masson CL, Linas BP. PMID: 29477574; PMCID: PMC5889754.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansPHPublic Health
    20. Structural factors affecting Asians and Pacific Islanders in community-based substance use treatment: Treatment provider perspectives. J Ethn Subst Abuse. 2017 Oct-Dec; 16(4):479-494. Chang JS, Sorensen JL, Masson CL, Shopshire MS, Hoffman K, McCarty D, Iguchi M. PMID: 29236627.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    21. Perceived discrimination among racial and ethnic minority drug users and the association with health care utilization. J Ethn Subst Abuse. 2017 Oct-Dec; 16(4):404-419. McKnight C, Shumway M, Masson CL, Pouget ER, Jordan AE, Des Jarlais DC, Sorensen JL, Perlman DC. PMID: 28306386; PMCID: PMC6155481.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    22. Hepatitis C Screening Rate Among Underserved Adults With Serious Mental Illness Receiving Care in California Community Mental Health Centers. Am J Public Health. 2016 Apr; 106(4):740-2. Trager E, Khalili M, Masson CL, Vittinghoff E, Creasman J, Mangurian C. PMID: 26890183; PMCID: PMC4816001.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    23. Scientific writing seminar to help early-stage investigators publish research. Drug and Alcohol Dependence. 2015 Nov 1; 156:e208. Sorensen SJ, Masson MC, Flentje FA, Shopshire SM, Guydish GJ. .
      View in: Publisher Site   Mentions:
    24. Acceptability of a mobile phone based hepatitis C intervention. Drug and Alcohol Dependence. 2015 Nov 1; 156:e127. Levine LJ, Cohen CS, Harkin HP, Guydish GJ, Sorensen SJ, Masson MC. .
      View in: Publisher Site   Mentions:
    25. An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs: Structural barriers and public health potential. Int J Drug Policy. 2015 Nov; 26(11):1056-63. Perlman DC, Jordan AE, Uuskula A, Huong DT, Masson CL, Schackman BR, Des Jarlais DC. PMID: 26050614; PMCID: PMC4581906.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansPHPublic Health
    26. Scientific writing seminar for early-stage investigators in substance abuse research. Subst Abus. 2016; 37(1):238-41. Guydish J, Masson C, Flentje A, Shopshire M, Sorensen JL. PMID: 25893689; PMCID: PMC4615274.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    27. Longitudinal analysis of pain and illicit drug use behaviors in outpatients on methadone maintenance. Drug Alcohol Depend. 2015 Apr 01; 149:285-9. Dhingra L, Perlman DC, Masson C, Chen J, McKnight C, Jordan AE, Wasser T, Portenoy RK, Cheatle MD. PMID: 25735466; PMCID: PMC4391061.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    28. Gender differences in hepatitis C risk behaviors. Drug and Alcohol Dependence. 2015 Jan 1; 146:e220. Batchelder BA, Masson MC, Sorensen SJ, Perlman PD. .
      View in: Publisher Site   Mentions:
    29. Viral hepatitis among drug users in methadone maintenance: associated factors, vaccination outcomes, and interventions. J Addict Dis. 2014; 33(4):322-31. Perlman DC, Jordan AE, McKnight C, Young C, Delucchi KL, Sorensen JL, Des Jarlais DC, Masson CL. PMID: 25299236; PMCID: PMC4275379.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    30. Education and counseling in the methadone treatment setting improves knowledge of viral hepatitis. J Subst Abuse Treat. 2014 Apr; 46(4):528-31. Larios SE, Masson CL, Shopshire MS, Hettema J, Jordan AE, McKnight C, Young C, Khalili M, Seewald RM, Min A, Hengl N, Sorensen JL, Des Jarlais DC, Perlman DC. PMID: 24462241; PMCID: PMC4019752.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    31. A randomized trial of a hepatitis care coordination model in methadone maintenance treatment. Am J Public Health. 2013 Oct; 103(10):e81-8. Masson CL, Delucchi KL, McKnight C, Hettema J, Khalili M, Min A, Jordan AE, Pepper N, Hall J, Hengl NS, Young C, Shopshire MS, Manuel JK, Coffin L, Hammer H, Shapiro B, Seewald RM, Bodenheimer HC, Sorensen JL, Des Jarlais DC, Perlman DC. PMID: 23947319; PMCID: PMC3853128.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansPHPublic Health
    32. Perceptions of drug users regarding hepatitis C screening and care: a qualitative study. Harm Reduct J. 2013 Jun 20; 10:10. Jordan AE, Masson CL, Mateu-Gelabert P, McKnight C, Pepper N, Bouche K, Guzman L, Kletter E, Seewald RM, Des-Jarlais DC, Sorensen JL, Perlman DC. PMID: 23786800; PMCID: PMC3695813.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    33. Effects of HCV seropositive status on buprenorphine pharmacokinetics in opioid-dependent individuals. Am J Addict. 2014 Jan-Feb; 23(1):34-40. Masson CL, Rainey PM, Moody DE, McCance-Katz EF. PMID: 24313239; PMCID: PMC3998818.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    34. Possible barriers to enrollment in substance abuse treatment among a diverse sample of Asian Americans and Pacific Islanders: opinions of treatment clients. J Subst Abuse Treat. 2013 Mar; 44(3):309-15. Masson CL, Shopshire MS, Sen S, Hoffman KA, Hengl NS, Bartolome J, McCarty D, Sorensen JL, Iguchi MY. PMID: 22985677; PMCID: PMC3545039.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    35. Epidemiology of pain among outpatients in methadone maintenance treatment programs. Drug Alcohol Depend. 2013 Feb 01; 128(1-2):161-5. Dhingra L, Masson C, Perlman DC, Seewald RM, Katz J, McKnight C, Homel P, Wald E, Jordan AE, Young C, Portenoy RK. PMID: 22951068; PMCID: PMC3546120.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    36. NIDA's Clinical Trials Network: an opportunity for HIV research in community substance abuse treatment programs. Am J Drug Alcohol Abuse. 2011 Sep; 37(5):283-93. Tross S, Campbell AN, Calsyn DA, Metsch LR, Sorensen JL, Shoptaw S, Haynes L, Woody GE, Malow RM, Brown LS, Feaster DJ, Booth RE, Mandler RN, Masson C, Holmes BW, Colfax G, Brooks AJ, Hien DA, Schackman BR, Korthuis PT, Miele GM, Clinical Trials Network HIV Special Interest Group. PMID: 21854270; PMCID: PMC3361073.
      View in: PubMed   Mentions: 3     Fields:    
    37. Organizational issues in the implementation of a hospital-based syringe exchange program. Subst Use Misuse. 2010 May; 45(6):901-15. Masson CL, Sorensen JL, Grossman N, Sporer KA, Des Jarlais DC, Perlman DC. PMID: 20397875; PMCID: PMC3378397.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    38. Residential treatment modifications: adjunctive services to accommodate clients on methadone. Am J Drug Alcohol Abuse. 2009; 35(2):91-4. Chen T, Masson CL, Sorensen JL, Greenberg B. PMID: 19259872; PMCID: PMC3558978.
      View in: PubMed   Mentions: 4     Fields:    
    39. Methadone patients in the therapeutic community: a test of equivalency. Drug Alcohol Depend. 2009 Feb 01; 100(1-2):100-6. Sorensen JL, Andrews S, Delucchi KL, Greenberg B, Guydish J, Masson CL, Shopshire M. PMID: 19013724; PMCID: PMC2606930.
      View in: PubMed   Mentions: 4     Fields:    
    40. Clinic appointment attendance for sexually transmitted infection screening among Filipina sex workers: a multilevel analysis. AIDS Care. 2007 Oct; 19(9):1166-70. Chiao C, Morisky DE, Ksobiech K, Masson CL, Malow RM. PMID: 18058401; PMCID: PMC3130545.
      View in: PubMed   Mentions: 3     Fields:    
    41. Hospital- versus community-based syringe exchange: a randomized controlled trial. AIDS Educ Prev. 2007 Apr; 19(2):97-110. Masson CL, Sorensen JL, Perlman DC, Shopshire MS, Delucchi KL, Chen T, Sporer K, Des Jarlais D, Hall SM. PMID: 17411413; PMCID: PMC3853200.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    42. Linking opioid-dependent hospital patients to drug treatment: Health care use and costs 6 months after randomization. Addiction. 2006 Dec; 101(12):1797-804. Barnett PG, Masson CL, Sorensen JL, Wong W, Hall S. PMID: 17156179.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    43. Psychometric evaluation of the Quality of Life Interview, Brief Version, in injection drug users. Psychol Addict Behav. 2006 Sep; 20(3):316-21. Wasserman DA, Sorensen JL, Delucchi KL, Masson CL, Hall SM. PMID: 16938069.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    44. Randomized trial of drug abuse treatment-linkage strategies. J Consult Clin Psychol. 2005 Dec; 73(6):1026-35. Sorensen JL, Masson CL, Delucchi K, Sporer K, Barnett PG, Mitsuishi F, Lin C, Song Y, Chen T, Hall SM. PMID: 16392976.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    45. Knowledge of hepatitis among active drug injectors at a syringe exchange program. J Subst Abuse Treat. 2005 Jul; 29(1):47-53. Carey J, Perlman DC, Friedmann P, Kaplan WM, Nugent A, Deutscher M, Masson CL, Des Jarlais DC. PMID: 15979531.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansPHPublic Health
    46. Spinal cord infarction: clinical and magnetic resonance imaging findings and short term outcome. J Neurol Neurosurg Psychiatry. 2004 Oct; 75(10):1431-5. Masson C, Pruvo JP, Meder JF, Cordonnier C, Touzé E, De La Sayette V, Giroud M, Mas JL, Leys D, Study Group on Spinal Cord Infarction of the French Neurovascular Society. PMID: 15377691; PMCID: PMC1738740.
      View in: PubMed   Mentions: 74     Fields:    Translation:Humans
    47. Predictors of medical service utilization among individuals with co-occurring HIV infection and substance abuse disorders. AIDS Care. 2004 Aug; 16(6):744-55. Masson CL, Sorensen JL, Phibbs CS, Okin RL. PMID: 15370062.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCTClinical Trials
    48. Cost and cost-effectiveness of standard methadone maintenance treatment compared to enriched 180-day methadone detoxification. Addiction. 2004 Jun; 99(6):718-26. Masson CL, Barnett PG, Sees KL, Delucchi KL, Rosen A, Wong W, Hall SM. PMID: 15139870.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    49. HIV/hepatitis prevention in drug abuse treatment programs: guidance from research. Sci Pract Perspect. 2002 Jul; 1(1):4-11. Sorensen JL, Masson CL, Perlman DC. PMID: 18567957; PMCID: PMC2851052.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    50. Medical service use and financial charges among opioid users at a public hospital. Drug Alcohol Depend. 2002 Mar 01; 66(1):45-50. Masson CL, Sorensen JL, Batki SL, Okin R, Delucchi KL, Perlman DC. PMID: 11850135.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    51. Mood disturbance fails to resolve across 31 days of cigarette abstinence in women. J Consult Clin Psychol. 2002 Feb; 70(1):142-52. Gilbert DG, McClernon FJ, Rabinovich NE, Plath LC, Masson CL, Anderson AE, Sly KF. PMID: 11860040.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    52. Violent traumatic events and drug abuse severity. J Subst Abuse Treat. 2001 Mar; 20(2):121-7. Clark HW, Masson CL, Delucchi KL, Hall SM, Sees KL. PMID: 11306214.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCTClinical Trials
    53. Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial. JAMA. 2000 Mar 08; 283(10):1303-10. Sees KL, Delucchi KL, Masson C, Rosen A, Clark HW, Robillard H, Banys P, Hall SM. PMID: 10714729.
      View in: PubMed   Mentions: 100     Fields:    Translation:HumansCTClinical Trials
    54. Cardiovascular and mood responses to quantified doses of cigarette smoke in oral contraceptive users and nonusers. J Behav Med. 1999 Dec; 22(6):589-604. Masson CL, Gilbert DG. PMID: 10650538.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    55. Providing public testimony: A guide for psychologists. Professional Psychology Research and Practice. 1998 Jan 1; 29(6):588. Sorensen SJ, Masson MC, Clark CW, Morin MS. .
      View in: Publisher Site   Mentions:
    56. Preventing opportunistic infections in HIV-infected injection drug users. JAMA. 1997 Dec 03; 278(21):1743-4. Perlman DC, Des Jarlais DC, Salomon N, Masson CL. PMID: 9388148.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    57. Cardiovascular responses to a quantified dose of nicotine as a function of personality and nicotine tolerance. J Behav Med. 1990 Oct; 13(5):505-21. Masson CL, Gilbert DG. PMID: 2273527.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    Carmen's Networks
    Concepts (198)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (20)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-15-g9ae42700 on PROFILES-PWEB03.

    Copyright © The Regents of the University of California.